Balchem (BCPC) Stock Price, News & Analysis

Company Overview

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers specialty vitamin K2; microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; methylsulfonylmethane; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment distributes ethylene oxide and ammonia primarily for use in the health care industry; and single use canisters for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. It sells its products through sales force, independent distributors, and sales agents. The company was incorporated in 1967 and is headquartered in Montvale, New Jersey.

Key Stats

• Today's Range: $161.67 to $165.12
• 50-Day Range: $148.82 to $165.12
• 52-Week Range: $145.70 to $185.96
• Volume: 227,790 shs
• Average Volume: 166,891 shs
• Market Capitalization: $5.26 billion
• P/E Ratio: 37.17
• Dividend Yield: 0.54%
• Price Target: $189.00
• Consensus Rating: Moderate Buy

Balchem Stock Analysis - MarketRank™

Balchem scored higher than 78% of companies evaluated by MarketBeat, and ranked 47th out of 187 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Balchem has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Balchem has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 10.99%

Earnings Growth

Earnings for Balchem are expected to grow by 10.99% in the coming year, from $4.64 to $5.15 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Balchem is 37.17, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 28.64.

Price to Earnings Ratio vs. Sector

The P/E ratio of Balchem is 37.17, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 113.38.

Price to Earnings Growth Ratio

Balchem has a PEG Ratio of 3.53. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Balchem has a P/B Ratio of 4.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.51% of the float of Balchem has been sold short.

Short Interest Ratio / Days to Cover

Balchem has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Balchem has recently increased by 1.92%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Balchem has a dividend yield of 0.54%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Balchem has been increasing its dividend for 16 years.

Dividend Coverage

The dividend payout ratio of Balchem is 19.95%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Balchem will have a dividend payout ratio of 16.89% next year. This indicates that Balchem will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 2.3 / 5
• Environmental Score: -1.54

Percentage of Shares Shorted

1.51% of the float of Balchem has been sold short.

Short Interest Ratio / Days to Cover

Balchem has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Balchem has recently increased by 1.92%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

1 people have searched for BCPC on MarketBeat in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Balchem insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 1.39% of the stock of Balchem is held by insiders.

Percentage Held by Institutions

87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

BCPC Stock Analysis - Frequently Asked Questions

How have BCPC shares performed this year?

Balchem's stock was trading at $162.99 at the beginning of the year. Since then, BCPC shares have decreased by 0.6% and is now trading at $162.06.

How were Balchem's earnings last quarter?

Balchem Corporation (NASDAQ:BCPC) announced its earnings results on Thursday, July, 31st. The basic materials company reported $1.27 earnings per share for the quarter, topping analysts' consensus estimates of $1.25 by $0.02. Balchem's quarterly revenue was up 9.1% compared to the same quarter last year.
Read the conference call transcript.

Does Balchem have any subsidiaries?

Balchem subsidiaries include these companies: Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and others.

Who are Balchem's major shareholders?

Top institutional investors of Balchem include State Street Corp (3.78%), Conestoga Capital Advisors LLC (3.52%), Geode Capital Management LLC (3.02%) and Wasatch Advisors LP (2.96%). Insiders that own company stock include Theodore L Harris, David B Fischer, Gunsteren Job Leonard Van, William A Backus and Michael Robert Sestrick.
View institutional ownership trends.

How do I buy shares of Balchem?

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Balchem own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

• Last Earnings: 7/31/2025
• Today: 8/25/2025
• Next Earnings (Estimated): 10/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: CHEM - SPECIALTY
• Sub-Industry: Specialty Chemicals
• Current Symbol: NASDAQ:BCPC
• Previous Symbol: NASDAQ:BCPC
• CIK: 9326
• Web: www.balchem.com
• Phone: (845) 326-5600
• Fax: 845-326-5717
• Employees: 1,361
• Year Founded: 1967

Price Target and Rating

• Average Price Target for Balchem: $189.00
• High Price Target: $189.00
• Low Price Target: $189.00
• Potential Upside/Downside: +15.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.36
• Trailing P/E Ratio: 37.42
• Forward P/E Ratio: 35.16
• P/E Growth: 3.53
• Net Income: $128.48 million
• Net Margins: 14.48%
• Pretax Margin: 18.80%
• Return on Equity: 12.41%
• Return on Assets: 9.21%

Debt

• Debt-to-Equity Ratio: 0.17
• Current Ratio: 2.64
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $985.93 million
• Price / Sales: 5.37
• Cash Flow: $5.36 per share
• Price / Cash Flow: 30.42
• Book Value: $35.37 per share
• Price / Book: 4.61

Miscellaneous

• Outstanding Shares: 32,455,000
• Free Float: 32,049,000
• Market Cap: $5.30 billion
• Optionable: Optionable
• Beta: 0.88